LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Начало・Списък с акции・Pfizer
Search

Pfizer

Затворен

СекторЗдравеопазване

25.9 0.04

Неутрален

Обновена цена 22.05.2026 г., 19:59 ч. UTC

КупиПродай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

25.9

Максимум

26

Ключови измерители

By Trading Economics

Приходи

4.3B

2.7B

Продажби

-3.1B

14B

P/E

Средно за сектора

19.336

49.701

EPS

0.75

Дивидентна доходност

6.79

Марж на печалбата

18.656

Служители

75,000

EBITDA

4.5B

5.2B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+12.63% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

6.79%

2.39%

Следващи печалби

4.08.2026 г.

Следваща дата на дивидент

12.06.2026 г.

Следваща дата на екс-дивидент

24.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-5.2B

144B

Предишно отваряне

25.86

Предишно затваряне

25.9

Настроения в новините

By Acuity

33%

67%

91 / 345 Класиране в Healthcare

Pfizer Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.05.2026 г., 11:31 ч. UTC

Печалби

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

DJ

Прочетени

5.05.2026 г., 18:12 ч. UTC

Печалби

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 13:54 ч. UTC

Печалби

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 12:35 ч. UTC

Печалби

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

DJ

Прочетени

5.05.2026 г., 11:06 ч. UTC

Печалби

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

DJ

Прочетени

5.05.2026 г., 10:47 ч. UTC

Печалби

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

DJ

Прочетени

5.05.2026 г., 10:47 ч. UTC

Печалби

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

DJ

Прочетени

5.05.2026 г., 10:46 ч. UTC

Печалби

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

DJ

Прочетени

5.05.2026 г., 10:46 ч. UTC

Печалби

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer Reaffirms 2026 Guidance >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer 1Q Rev $14.5B >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer 1Q EPS 47c >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer 1Q Net $2.69B >PFE

DJ

Прочетени

5.05.2026 г., 10:45 ч. UTC

Печалби

Pfizer 1Q Adj EPS 75c >PFE

DJ

Прочетени

5.05.2026 г., 10:36 ч. UTC

Горещи акции

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

DJ

Прочетени

23.04.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

DJ

Прочетени

1.04.2026 г., 20:07 ч. UTC

Придобивния, сливания и поглъщания

Why 2026 Is Biotech's Comeback Year -- Barrons.com

DJ

Прочетени

11.03.2026 г., 11:02 ч. UTC

Пазарно говорене

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

DJ

Прочетени

10.03.2026 г., 12:50 ч. UTC

Печалби

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

DJ

Прочетени

10.03.2026 г., 11:18 ч. UTC

Печалби

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

DJ

Прочетени

9.03.2026 г., 09:43 ч. UTC

Горещи акции

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

DJ

Прочетени

10.02.2026 г., 21:51 ч. UTC

Печалби

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

DJ

Прочетени

10.02.2026 г., 21:17 ч. UTC

Печалби

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

DJ

Прочетени

3.02.2026 г., 21:36 ч. UTC

Печалби

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

DJ

Прочетени

3.02.2026 г., 19:56 ч. UTC

Печалби

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

DJ

Прочетени

3.02.2026 г., 19:46 ч. UTC

Печалби

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

DJ

Прочетени

3.02.2026 г., 17:35 ч. UTC

Печалби

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

DJ

Прочетени

3.02.2026 г., 17:30 ч. UTC

Печалби

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

DJ

Прочетени

Сравнение с други в отрасъла

Ценова промяна

Pfizer Прогноза

Ценова цел

By TipRanks

12.63% нагоре

12-месечна прогноза

Среден 29.17 USD  12.63%

Висок 36 USD

Нисък 25 USD

Според 22 анализатори от Wall Street, предложили 12-месечна ценова цел за Pfizer през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

22 ratings

8

Купи

11

Задържане

3

Продай

Според 22 анализатори, дали борсови рейтинги на Pfizer през последните 3 месеца.

Настроение

By Acuity

91 / 345 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Други акции от сектора

LLY

Eli Lilly and Co.

1,066.82

↑ +2.48%

JNJ

Johnson and Johnson

234.57

↑ +1.33%

ABBV

AbbVie Inc

216.12

↑ +0.45%

UNH

UnitedHealth Group Inc

388.17

↑ +1.5%

AZN

AstraZeneca PLC

187.25

↓-1.32%
help-icon Live chat